SUCCESSFUL TREATMENT OF LEVODOPA-INDUCED MYOCLONUS AND LEVODOPA WITHDRAWAL-INDUCED NEUROLEPTIC MALIGNANT SYNDROME - A CASE-REPORT

被引：14

作者：

HIRSCHORN, KA ^{[1
]}

GREENBERG, HS ^{[1
]}

机构：

[1] UNIV MICHIGAN HOSP,DEPT NEUROL,1914-0316 TAUBMAN CTR,ANN ARBOR,MI 48109

来源：

CLINICAL NEUROPHARMACOLOGY | 1988年 / 11卷 / 03期

关键词：

D O I：

10.1097/00002826-198806000-00011

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：278 / 281

页数：4

共 19 条

[1]

BEDARD P, 1974, LANCET, V1, P738

[2] NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].

BURKE, RE ;

FAHN, S ;

MAYEUX, R ;

WEINBERG, H ;

LOUIS, K ;

WILLNER, JH .

NEUROLOGY, 1981, 31 (08) :1022-1026

[3]

CHADWICK D, 1974, LANCET, V2, P111

[4] CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE-OXIDASE INHIBITOR, AND CLONAZEPAM [J].

CHADWICK, D ;

HALLETT, M ;

HARRIS, R ;

JENNER, P ;

REYNOLDS, EH ;

MARSDEN, CD .

BRAIN, 1977, 100 (SEP) :455-487

[5]

COLEMAN M, 1971, NEUROLOGY, V21, P421

[6] INFANTILE SPASMS ASSOCIATED WITH 5-HYDROXYTRYPTOPHAN ADMINISTRATION IN PATIENTS WITH DOWNS SYNDROME [J].

COLEMAN, M .

NEUROLOGY, 1971, 21 (09) :911-&

[7]

DELEAN J, 1976, NEUROLOGY, V26, P863

[8]

FRIEDMAN JH, 1984, ANN NEUROL, V16, P126

[9] NEUROLEPTIC MALIGNANT SYNDROME RESPONSIVE TO CARBIDOPA LEVODOPA - SUPPORT FOR A DOPAMINERGIC PATHOGENESIS [J].

HARRIS, M ;

NORA, L ;

TANNER, CM .

CLINICAL NEUROPHARMACOLOGY, 1987, 10 (02) :186-189

[10] NEUROLEPTIC MALIGNANT SYNDROME - A PATHOGENETIC ROLE FOR DOPAMINE RECEPTOR BLOCKADE [J].

HENDERSON, VW ;

WOOTEN, GF .

NEUROLOGY, 1981, 31 (02) :132-137

← 1 2 →